Chen Y, Wei M, Wang C, Lee H, Pan S, Gao M, et al. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer. Cancer Lett. 2015;357:582-90 pubmed 出版商

Rodgers S, Ferguson D, Mitchell C, Ooms L. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases. Biosci Rep. 2017;37: pubmed 出版商

Amoroso M, Matassa D, Agliarulo I, Avolio R, Lu H, Sisinni L, et al. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition. Cell Death Dis. 2016;7:e2522 pubmed 出版商

Yuan F, XU M, Li X, Xinlong H, Fang W, Dong J. The Roles of Acidosis in Osteoclast Biology. Front Physiol. 2016;7:222 pubmed 出版商

Chandra V, Karamitri A, Richards P, Cormier F, Ramond C, Jockers R, et al. Extracellular acidification stimulates GPR68 mediated IL-8 production in human pancreatic β cells. Sci Rep. 2016;6:25765 pubmed 出版商

Yu R, Yu B, Chen J, Lv X, Yan Z, Cheng Y, et al. Anti-tumor effects of Atractylenolide I on bladder cancer cells. J Exp Clin Cancer Res. 2016;35:40 pubmed 出版商

Wang H, Liu W, Black S, Turner O, Daniel J, Dean Colomb W, et al. Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression. Oncotarget. 2016;7:5677-89 pubmed 出版商

Kong D, Li S, Du Z, Liu C, Liu B, Li C, et al. BAG3 elevation inhibits cell proliferation via direct interaction with G6PD in hepatocellular carcinomas. Oncotarget. 2016;7:700-11 pubmed 出版商

Tsurumaki H, Mogi C, Aoki Saito H, Tobo M, Kamide Y, Yatomi M, et al. Protective Role of Proton-Sensing TDAG8 in Lipopolysaccharide-Induced Acute Lung Injury. Int J Mol Sci. 2015;16:28931-42 pubmed 出版商

Qin H, Sha J, Jiang C, Gao X, Qu L, Yan H, et al. miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells. Onco Targets Ther. 2015;8:3175-84 pubmed 出版商

Liu M, Qi Z, Liu B, Ren Y, Li H, Yang G, et al. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway. Oncotarget. 2015;6:25281-94 pubmed 出版商

Cohen Solal K, Boregowda R, Lasfar A. RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression. Mol Cancer. 2015;14:137 pubmed 出版商

Tobo A, Tobo M, Nakakura T, Ebara M, Tomura H, Mogi C, et al. Characterization of Imidazopyridine Compounds as Negative Allosteric Modulators of Proton-Sensing GPR4 in Extracellular Acidification-Induced Responses. PLoS ONE. 2015;10:e0129334 pubmed 出版商

Yuan F, Zhao M, Jiang L, Wang H, Cao L, Zhou X, et al. Molecular actions of ovarian cancer G protein-coupled receptor 1 caused by extracellular acidification in bone. Int J Mol Sci. 2014;15:22365-73 pubmed 出版商

Park M, Kim B, Dong S, Lee S, Kim D, Rho S. The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1? expression. Oncotarget. 2014;5:4935-44 pubmed

Ren W, Liu Y, Wan S, Fei C, Wang W, Chen Y, et al. BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways. PLoS ONE. 2014;9:e96816 pubmed 出版商

Muniz Feliciano L, Van Grol J, Portillo J, Liew L, Liu B, Carlin C, et al. Toxoplasma gondii-induced activation of EGFR prevents autophagy protein-mediated killing of the parasite. PLoS Pathog. 2013;9:e1003809 pubmed 出版商

Song T, Wang L, Mo Z, Mao L, Ma X, Niu R, et al. Expression of p-Akt in ovarian serous carcinoma and its association with proliferation and apoptosis. Oncol Lett. 2014;7:59-64 pubmed

Juvin V, Malek M, Anderson K, Dion C, Chessa T, Lecureuil C, et al. Signaling via class IA Phosphoinositide 3-kinases (PI3K) in human, breast-derived cell lines. PLoS ONE. 2013;8:e75045 pubmed 出版商

Leal P, Garcia P, Sandoval A, Buchegger K, Weber H, Tapia O, et al. AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines. Onco Targets Ther. 2013;6:1373-84 pubmed 出版商

Dobbin Z, Landen C. The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer. Int J Mol Sci. 2013;14:8213-27 pubmed 出版商

De Marco C, Rinaldo N, Bruni P, Malzoni C, Zullo F, Fabiani F, et al. Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma. PLoS ONE. 2013;8:e55362 pubmed 出版商

Lee H, Kim J, Kim E. Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways. PLoS ONE. 2012;7:e50624 pubmed 出版商

McCubrey J, Steelman L, Chappell W, Abrams S, Montalto G, Cervello M, et al. Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response. Oncotarget. 2012;3:954-87 pubmed

He J, Xu Q, Wang M, Li C, Qian X, Shi Z, et al. Oral administration of apigenin inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model. Int J Mol Sci. 2012;13:7271-82 pubmed 出版商

Virtakoivu R, Pellinen T, Rantala J, Perälä M, Ivaska J. Distinct roles of AKT isoforms in regulating ?1-integrin activity, migration, and invasion in prostate cancer. Mol Biol Cell. 2012;23:3357-69 pubmed 出版商

Saji M, Narahara K, McCarty S, Vasko V, La Perle K, Porter K, et al. Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer. Oncogene. 2011;30:4307-15 pubmed 出版商

Kumar R, Blakemore S, Ellis C, Petricoin E, Pratt D, Macoritto M, et al. Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693. BMC Genomics. 2010;11:419 pubmed 出版商

Smith D, Patel S, Raffoul F, Haller E, Mills G, Nanjundan M. Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells. Cell Death Differ. 2010;17:1867-81 pubmed 出版商